| Dean Morgan Hilger, DDS | |
|
2420 Main St, Su1, Cambria, CA 93428-3406 | |
| (805) 927-4609 | |
| (805) 927-1799 |
| Full Name | Dean Morgan Hilger |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 2420 Main St, Cambria, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053445379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 24555 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dean Morgan Hilger, DDS 2420 Main Street, Su1, Cambria, CA 93428-3406 Ph: (805) 927-4609 | Dean Morgan Hilger, DDS 2420 Main St, Su1, Cambria, CA 93428-3406 Ph: (805) 927-4609 |
News Archive
The prevalence of allergic diseases has increased significantly over the last decades, creating substantial financial and societal burdens. Due to this, researchers are trying to discover new approaches to the prevention and treatment of these diseases.
Academics are to look at ways to encourage Scots to take part in a new national screening programme for bowel cancer, a leading cause of cancer deaths in Western nations.
On Friday, March 13, 2015, as part of its 20th Annual Conference: Advancing the Standard of Cancer Care, the National Comprehensive Cancer Network hosted its second roundtable, Value-Based Decision-Making at the Bedside, which reflected on the tools available to oncology clinicians, such as clinical practice guidelines and pathways, and how the use of these tools has impacted bedside evidence-based decision-making for both physicians and patients, the criteria used to assess shared decision-making, and the relationship between outcomes and cost when determining value.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and others proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, today announced financial results for the first quarter ended March 31, 2014.
Doctors would like to diagnose malignancies rapidly by matching them with highly-specific genetic "mug shots" based on the presence of characteristic mRNAs or proteins. This kind of specificity would facilitate screening and early detection, and would potentially allow targeted treatments specific to each type of cancer
› Verified 3 days ago
Dr. Jill Elizabeth Poulos, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 4235 Bridge St, Cambria, CA 93428 Phone: 805-927-5797 | |
Dr. Frank S. Fratto Jr., D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 2150 Main St, Cambria, CA 93428 Phone: 805-927-4811 Fax: 805-927-0818 | |
Dr. Phillip Opperman, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2150 Main St, Suite 4, Cambria, CA 93428 Phone: 805-927-4811 Fax: 805-927-0818 | |
James William Willis, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2150 Main St, Suite 4, Cambria, CA 93428 Phone: 805-927-4811 |